Format
Sort by

Send to

Choose Destination

Search results

Items: 19

1.

Tessier 3 Cleft in a Pre-Hispanic Anthropomorphic Figurine in El Salvador, Central America.

Aleman RM, Martinez MG.

Cleft Palate Craniofac J. 2016 Mar 28. [Epub ahead of print]

PMID:
27018526
2.

Streptozotocin-induced diabetes, and the optic nerve blood barrier.

Alemán R, Mompeó B, Castaño I.

Arch Soc Esp Oftalmol. 2016 Apr;91(4):170-6. doi: 10.1016/j.oftal.2015.12.017. Epub 2016 Jan 29. English, Spanish.

PMID:
26832629
3.

Lateral thigh fascia lata as interpositional graft for temporomandibular joint ankylosis.

Alemán RM, Martínez MG.

J Maxillofac Oral Surg. 2012 Sep;11(3):354-7. doi: 10.1007/s12663-011-0304-z. Epub 2011 Oct 18.

4.

Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C.

García-Samaniego J, Romero M, Granados R, Alemán R, Jorge Juan M, Suárez D, Pérez R, Castellano G, González-Portela C.

World J Gastroenterol. 2013 Mar 28;19(12):1943-52. doi: 10.3748/wjg.v19.i12.1943.

5.

Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis C.

Vispo E, Labarga P, Guardiola JM, Barreiro P, Miralles C, Rubio R, Miralles P, Aguirrebengoa K, Portu J, Morello J, Rodriguez-Novoa S, Soriano V; PERICO Study Group.

AIDS Res Hum Retroviruses. 2010 Apr;26(4):419-24. doi: 10.1089/aid.2009.0120.

PMID:
20377423
6.

Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practice.

Macías J, González J, Ortega E, Tural C, Cabrero E, Burgos A, Pineda JA; GRAFIHCO Study Team.

HIV Med. 2010 Aug;11(7):439-47. doi: 10.1111/j.1468-1293.2009.00812.x. Epub 2010 Feb 17.

7.

Prevalence and impact of body physical changes in HIV patients treated with highly active antiretroviral therapy: results from a study on patient and physician perceptions.

Cabrero E, Griffa L, Burgos A; HIV Body Physical Changes Study Group.

AIDS Patient Care STDS. 2010 Jan;24(1):5-13. doi: 10.1089/apc.2009.0191.

PMID:
20095903
8.

Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients.

Pineda JA, González J, Ortega E, Tural C, Macías J, Griffa L, Burgos A; Grafihco Study Team.

J Viral Hepat. 2010 Oct;17(10):714-9. doi: 10.1111/j.1365-2893.2009.01229.x.

PMID:
20002560
9.

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis.

Arribas JR, Delgado R, Arranz A, Muñoz R, Portilla J, Pasquau J, Pérez-Elias MJ, Iribarren JA, Rubio R, Ocampo A, Sánchez-Conde M, Knobel H, Arazo P, Sanz J, López-Aldeguer J, Montes ML, Pulido F; OK04 Study Group.

J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):147-52. doi: 10.1097/QAI.0b013e3181a56de5.

PMID:
19349870
10.

Fosamprenavir (GW433908)/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access Program.

Pérez-Elias MJ, Sánchez-Conde M, Soriano V, Mallolas J, Luque I, Rodríguez-Alcántara F; Fosamprenavir Expanded Access Program Group.

Enferm Infecc Microbiol Clin. 2009 Jan;27(1):28-32. doi: 10.1016/j.eimc.2008.05.002. Epub 2009 Jan 9.

PMID:
19218000
11.

Diabetic retinopathy and blindness in Spain: epidemiology and prevention.

Vila L, Viguera J, Alemán R.

Endocrinol Nutr. 2008 Dec;55(10):459-75. doi: 10.1016/S1575-0922(08)75843-1. Epub 2009 Jan 7. English, Spanish.

PMID:
22980462
12.

Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens.

Pineda JA, Pérez-Elías MJ, Peña JM, Luque I, Rodríguez-Alcantara F; Fosamprenavir Expanded Access Program Group.

HIV Clin Trials. 2008 Sep-Oct;9(5):309-13. doi: 10.1310/hct0905-309.

PMID:
18977719
13.

Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy.

Gutiérrez F, Padilla S, Masiá M, Iribarren JA, Moreno S, Viciana P, Hernández-Quero J, Alemán R, Vidal F, Salavert M, Blanco JR, Leal M, Dronda F, Perez Hoyos S, del Amo J; CoRIS-MD.

Curr HIV Res. 2008 Mar;6(2):100-7.

PMID:
18336257
14.

[Diarrhoea in the traveller].

Alonso Socas MM, Alemán R, López Lirola R, Castellano A, Martín Ponce E, Gómez Sirvent JL.

An Sist Sanit Navar. 2006;29 Suppl 1:127-38. Review. Spanish.

PMID:
16721423
15.

Purple membrane-polyacrilamide films as holographic recording materials.

Fimia A, Acebal P, Murciano A, Blaya S, Carretero L, Ulibarrena M, Aleman R, Gomariz M, Meseguer I.

Opt Express. 2003 Dec 15;11(25):3438-44.

PMID:
19471476
16.

Chromatographic removal combined with heat, acid and chaotropic inactivation of four model viruses.

Valdés R, Ibarra N, Ruibal I, Beldarraín A, Noa E, Herrera N, Alemán R, Padilla S, Garcia J, Pérez M, Morales R, Chong E, Reyes B, Quiñones Y, Agraz A, Herrera L.

J Biotechnol. 2002 Jul 3;96(3):251-8.

PMID:
12044553
17.

Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma.

Llanos M, Alvarez-Argüelles H, Alemán R, Oramas J, Diaz-Flores L, Batista N.

Med Oncol. 2001;18(1):15-22.

PMID:
11778965
18.

Non-viral gene delivery: vehicle and delivery characterization.

Lollo CP, Kwoh DY, Mockler TC, Ley PM, Guido MS, Coffin CC, Aleman R, Bartholomew RM, Carlo DJ.

Blood Coagul Fibrinolysis. 1997 Dec;8 Suppl 2:S31-8.

PMID:
9607111
19.

Hemolytic anemia of the newborn (erythroblastosis fetalis) report of cases.

ALEMAN RG.

New Orleans Med Surg J. 1945 Dec;98:278-80. No abstract available.

PMID:
21006236
Items per page

Supplemental Content

Loading ...
Write to the Help Desk